URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Robert Holloway

TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentNeurology
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 673
Rochester NY 14642
Other Positions
TitleChair
InstitutionSchool of Medicine and Dentistry
DepartmentNeurology

 
 Awards And Honors
1984     University Scholar  | University of Connecticut
1985     Phi Beta Kappa  | University of Connecticut
1985     Olin Award for Excellence in Undergraduate Research in Cellular and Molecular Biology  | University of Connecticut
1998     ISTAHC Award for 1997 for finest article published in 1997 " Mushlin AI, Mooney C, Holloway RG, Detsky AS, Mattson DH, Phelps CE. The cost-effectiveness of magnetic resonance imaging in patients with equivocal neurological symptoms. Int J Technol Assess Health Care, 1997:13:21-34.
1998     Quality Achievement Award for Physician Leadership in Performance Improvement  | University of Rochester
2002 - 2003Harry L. Segal Prize for Excellence in Third Year Teaching  | University of Rochester School of Medicine and Dentistry
2002 - 2003Neurology Faculty Teaching Award  | University of Rochester School of Medicine and Dentistry
2004     Teacher Recognition Award  | American Academy of Neurology
2005     Medical Center Board Excellence Award  | Palliative Care Team
2006     Neurology Senior Faculty Teaching Award  | University of Rochester School of Medicine and Dentistry
2006     Leadership Development for Physicians in Academic Health Centers  | The Department of Health Policy and Management
2006     Nominee  | AAMC Humanism in Medicine Award
2006     Co-Chair  | Stroke & Stroke Rehabilitation Work Group-Physician Consortium f
2007 - 2012Best Doctors in America  | Best Doctors, Inc.
2008     Junior Faculty Mentoring Award  | University of Rochester Medical Center
2011     Alpha Omega Alpha Faculty Inductee  | University of Rochester
 
 Overview
Dr. Holloway's major research interests are technology assessment and cost-effectiveness of neurological practices and policies, methods to improve the quality and safety of medical care, and conflicts of interest in research and practice.

 
 Selected Publications
List All   |   Timeline
  1. Wilson R, Kieburtz K, Holloway RG, Kim SY. Evidence-based research ethics and determinations of "engagement in research". IRB. 2014 Mar-Apr; 36(2):10-3.
    View in: PubMed
  2. Kelly AG, Zahuranec DB, Holloway RG, Morgenstern LB, Burke JF. Variation in do-not-resuscitate orders for patients with ischemic stroke: implications for national hospital comparisons. Stroke. 2014 Mar; 45(3):822-7.
    View in: PubMed
  3. Kelly AG, Sahin B, Holloway RG. Ethical considerations in stroke patients. Curr Opin Neurol. 2014 Feb; 27(1):61-5.
    View in: PubMed
  4. Katzan IL, Spertus J, Bettger JP, Bravata DM, Reeves MJ, Smith EE, Bushnell C, Higashida RT, Hinchey JA, Holloway RG, Howard G, King RB, Krumholz HM, Lutz BJ, Yeh RW. Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2014 Mar; 45(3):918-44.
    View in: PubMed
  5. Sollenberger JF, Holloway RG. The evolving role and value of libraries and librarians in health care. JAMA. 2013 Sep 25; 310(12):1231-2.
    View in: PubMed
  6. Dodel R, Jönsson B, Reese JP, Winter Y, Martinez-Martin P, Holloway R, Sampaio C, Ružicka E, Hawthorne G, Oertel W, Poewe W, Stebbins G, Rascol O, Goetz CG, Schrag A. Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease. Mov Disord. 2014 Feb; 29(2):169-76.
    View in: PubMed
  7. Holloway RG, Gramling R, Kelly AG. Estimating and communicating prognosis in advanced neurologic disease. Neurology. 2013 Feb 19; 80(8):764-72.
    View in: PubMed
  8. Benesch CG, Holloway RG. Too important to fail. Ann Neurol. 2013 Feb; 73(2):153-4.
    View in: PubMed
  9. Kim SY, de Vries R, Wilson R, Parnami S, Frank S, Kieburtz K, Holloway RG. Research participants' "irrational" expectations: common or commonly mismeasured? IRB. 2013 Jan-Feb; 35(1):1-9.
    View in: PubMed
  10. Manchak M, Holloway R. Adding clopidogrel to aspirin did not reduce recurrent stroke and increased bleeding in lacunar stroke. Ann Intern Med. 2012 Dec 18; 157(12):JC6-2.
    View in: PubMed
  11. Creutzfeldt CJ, Holloway RG. Treatment decisions after severe stroke: uncertainty and biases. Stroke. 2012 Dec; 43(12):3405-8.
    View in: PubMed
  12. Secord AA, Geller MA, Broadwater G, Holloway R, Shuler K, Dao NY, Gehrig PA, O'Malley DM, Finkler N, Havrilesky LJ. A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer. Gynecol Oncol. 2013 Jan; 128(1):65-70.
    View in: PubMed
  13. Kaye SB, Fehrenbacher L, Holloway R, Amit A, Karlan B, Slomovitz B, Sabbatini P, Fu L, Yauch RL, Chang I, Reddy JC. A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission. Clin Cancer Res. 2012 Dec 1; 18(23):6509-18.
    View in: PubMed
  14. Weaver FM, Stroupe KT, Cao L, Holloway RG, Vickrey BG, Simuni T, Hendricks A, Ippolito D. Parkinson's disease medication use and costs following deep brain stimulation. Mov Disord. 2012 Sep 15; 27(11):1398-403.
    View in: PubMed
  15. Kelly AG, Hoskins KD, Holloway RG. Early stroke mortality, patient preferences, and the withdrawal of care bias. Neurology. 2012 Aug 28; 79(9):941-4.
    View in: PubMed
  16. Kim SY, De Vries R, Holloway RG, Wilson R, Parnami S, Kim HM, Frank S, Kieburtz K. Sham surgery controls in Parkinson's disease clinical trials: views of participants. Mov Disord. 2012 Sep 15; 27(11):1461-5.
    View in: PubMed
  17. Quill TE, Holloway RG. Evidence, preferences, recommendations--finding the right balance in patient care. N Engl J Med. 2012 May 3; 366(18):1653-5.
    View in: PubMed
  18. Xian Y, Holloway RG, Pan W, Peterson ED. Challenges in assessing hospital-level stroke mortality as a quality measure: comparison of ischemic, intracerebral hemorrhage, and total stroke mortality rates. Stroke. 2012 Jun; 43(6):1687-90.
    View in: PubMed
  19. Kim SY, Wilson RM, Kim HM, Holloway RG, De Vries RG, Frank SA, Kieburtz K. Comparison of enrollees and decliners of Parkinson disease sham surgery trials. Mov Disord. 2012 Apr; 27(4):506-11.
    View in: PubMed
  20. Creutzfeldt CJ, Holloway RG, Walker M. Symptomatic and palliative care for stroke survivors. J Gen Intern Med. 2012 Jul; 27(7):853-60.
    View in: PubMed
  21. Heatwole C, Johnson N, Holloway R, Noyes K. Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study. J Clin Neuromuscul Dis. 2011 Dec; 13(2):85-94.
    View in: PubMed
  22. Holloway RG. In lieu of flowers…. J Palliat Med. 2011 Dec; 14(12):1348-9.
    View in: PubMed
  23. Ramirez PT, Adams S, Boggess JF, Burke WM, Frumovitz MM, Gardner GJ, Havrilesky LJ, Holloway R, Lowe MP, Magrina JF, Moore DH, Soliman PT, Yap S. Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. Gynecol Oncol. 2012 Feb; 124(2):180-4.
    View in: PubMed
  24. Quill TE, Holloway R. Time-limited trials near the end of life. JAMA. 2011 Oct 5; 306(13):1483-4.
    View in: PubMed
  25. Noyes K, Bajorska A, Chappel A, Schwid SR, Mehta LR, Weinstock-Guttman B, Holloway RG, Dick AW. Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study. Neurology. 2011 Jul 26; 77(4):355-63.
    View in: PubMed
  26. Holloway RG, Ringel SP. Getting to value in neurological care: a roadmap for academic neurology. Ann Neurol. 2011 Jun; 69(6):909-18.
    View in: PubMed
  27. Olden AM, Holloway R, Ladwig S, Quill TE, van Wijngaarden E. Palliative care needs and symptom patterns of hospitalized elders referred for consultation. J Pain Symptom Manage. 2011 Sep; 42(3):410-8.
    View in: PubMed
  28. Hyland MH, Holloway RG. Pearls & Oy-sters: a stroke of luck: detecting type A aortic dissection by MRA. Neurology. 2011 Feb 22; 76(8):e31-3.
    View in: PubMed
  29. Xian Y, Holloway RG, Noyes K, Shah MN, Friedman B. Racial differences in mortality among patients with acute ischemic stroke: an observational study. Ann Intern Med. 2011 Feb 1; 154(3):152-9.
    View in: PubMed
  30. Xian Y, Holloway RG, Chan PS, Noyes K, Shah MN, Ting HH, Chappel AR, Peterson ED, Friedman B. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA. 2011 Jan 26; 305(4):373-80.
    View in: PubMed
  31. Singh R, Nind G, Tucker G, Nguyen N, Holloway R, Bate J, Shetti M, George B, Tam W. Narrow-band imaging in the evaluation of villous morphology: a feasibility study assessing a simplified classification and observer agreement. Endoscopy. 2010 Nov; 42(11):889-94.
    View in: PubMed
  32. Young KC, Holloway RG, Burgin WS, Benesch CG. A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy. J Stroke Cerebrovasc Dis. 2010 Sep-Oct; 19(5):404-9.
    View in: PubMed
  33. Kelly AG, Holloway RG. Health state preferences and decision-making after malignant middle cerebral artery infarctions. Neurology. 2010 Aug 24; 75(8):682-7.
    View in: PubMed
  34. Kim SY, Holloway RG. Is it research?: an increasingly common question. Neurology. 2010 Jul 13; 75(2):102-4.
    View in: PubMed
  35. Holloway RG, Quill TE. Treatment decisions after brain injury--tensions among quality, preference, and cost. N Engl J Med. 2010 May 13; 362(19):1757-9.
    View in: PubMed
  36. Holloway RG, Ladwig S, Robb J, Kelly A, Nielsen E, Quill TE. Palliative care consultations in hospitalized stroke patients. J Palliat Med. 2010 Apr; 13(4):407-12.
    View in: PubMed
  37. Xian Y, Pan W, Peterson ED, Heidenreich PA, Cannon CP, Hernandez AF, Friedman B, Holloway RG, Fonarow GC. Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals. Am Heart J. 2010 Feb; 159(2):207-14.
    View in: PubMed
  38. Olden AM, Holloway R. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis. J Palliat Med. 2010 Jan; 13(1):59-65.
    View in: PubMed
  39. Pogoda TK, Cramer IE, Meterko M, Lin H, Hendricks A, Holloway RG, Charns MP. Patient and organizational factors related to education and support use by Veterans with Parkinson's disease. Mov Disord. 2009 Oct 15; 24(13):1916-24.
    View in: PubMed
  40. Dorsey ER, Thompson JP, Carrasco M, de Roulet J, Vitticore P, Nicholson S, Johnston SC, Holloway RG, Moses H. Financing of U.S. biomedical research and new drug approvals across therapeutic areas. PLoS One. 2009; 4(9):e7015.
    View in: PubMed
  41. Friedman D, Feldon S, Holloway R, Fisher S. Utilization, diagnosis, treatment and cost of migraine treatment in the emergency department. Headache. 2009 Sep; 49(8):1163-73.
    View in: PubMed
  42. Yurcheshen ME, Guttuso T, McDermott M, Holloway RG, Perlis M. Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model. J Womens Health (Larchmt). 2009 Sep; 18(9):1355-60.
    View in: PubMed
  43. Kim SY, Schrock L, Wilson RM, Frank SA, Holloway RG, Kieburtz K, de Vries RG. An approach to evaluating the therapeutic misconception. IRB. 2009 Sep-Oct; 31(5):7-14.
    View in: PubMed
  44. Dorsey ER, Thompson JP, Dayoub EJ, George B, Saubermann LA, Holloway RG. Selegiline shortage: Causes and costs of a generic drug shortage. Neurology. 2009 Jul 21; 73(3):213-7.
    View in: PubMed
  45. Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, Handschu R, Jauch EC, Knight WA, Levine SR, Mayberg M, Meyer BC, Meyers PM, Skalabrin E, Wechsler LR. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2009 Jul; 40(7):2616-34.
    View in: PubMed
  46. Dorsey ER, Thompson JP, Frasier M, Sherer T, Fiske B, Nicholson S, Johnston SC, Holloway RG, Moses H. Funding of Parkinson research from industry and US federal and foundation sources. Mov Disord. 2009 Apr 15; 24(5):731-7.
    View in: PubMed
  47. Holloway RG, Benesch C. When disclosures are more interesting than the evidence. Stroke. 2009 Feb; 40(2):e44; author reply e45.
    View in: PubMed
  48. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70.
    View in: PubMed
  49. Kelly A, Thompson JP, Tuttle D, Benesch C, Holloway RG. Public reporting of quality data for stroke: is it measuring quality? Stroke. 2008 Dec; 39(12):3367-71.
    View in: PubMed
  50. Thompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG. Quantitative risk-benefit analysis of natalizumab. Neurology. 2008 Jul 29; 71(5):357-64.
    View in: PubMed
  51. Kim SY, Holloway RG, Frank S, Wilson R, Kieburtz K. Trust in early phase research: therapeutic optimism and protective pessimism. Med Health Care Philos. 2008 Dec; 11(4):393-401.
    View in: PubMed
  52. Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO. Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines. Neurology. 2008 Jul 1; 71(1):57-63.
    View in: PubMed
  53. Bever CT, Holloway RG, Iverson DJ, Dubinsky RM, Richardson RM, Sheffield JK, Wang DZ, Franklin GM, Miyasaki JM, Tonn ST, Stevens JC. Invited article: Neurology and quality improvement: an introduction. Neurology. 2008 Apr 29; 70(18):1636-40.
    View in: PubMed
  54. O'Connor AB, Noyes K, Holloway RG. A cost-utility comparison of four first-line medications in painful diabetic neuropathy. Pharmacoeconomics. 2008; 26(12):1045-64.
    View in: PubMed
  55. Frank SA, Wilson R, Holloway RG, Zimmerman C, Peterson DR, Kieburtz K, Kim SY. Ethics of sham surgery: perspective of patients. Mov Disord. 2008 Jan; 23(1):63-8.
    View in: PubMed
  56. Dorsey ER, Holloway RG. Quality of life in epilepsy, multiple sclerosis, and beyond. Ann Neurol. 2007 Oct; 62(4):307-8.
    View in: PubMed
  57. Holloway RG, Quill TE. Mortality as a measure of quality: implications for palliative and end-of-life care. JAMA. 2007 Aug 15; 298(7):802-4.
    View in: PubMed
  58. O'Connor AB, Noyes K, Holloway RG. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia. J Am Geriatr Soc. 2007 Aug; 55(8):1176-84.
    View in: PubMed
  59. Biglan KM, Holloway RG, McDermott MP, Richard IH. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology. 2007 Jul 10; 69(2):187-95.
    View in: PubMed
  60. Norton SA, Hogan LA, Holloway RG, Temkin-Greener H, Buckley MJ, Quill TE. Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients. Crit Care Med. 2007 Jun; 35(6):1530-5.
    View in: PubMed
  61. Noyes K, Dick AW, Holloway RG. The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation. Med Decis Making. 2007 May-Jun; 27(3):327-34.
    View in: PubMed
  62. Dorsey ER, Thompson JP, Noyes K, Dick AW, Holloway RG, Schwid SR. Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis. Neurology. 2007 May 1; 68(18):1524-8.
    View in: PubMed
  63. Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S. Health care costs decline after successful epilepsy surgery. Neurology. 2007 Apr 17; 68(16):1290-8.
    View in: PubMed
  64. Noyes K, Liu H, Holloway R, Dick AW. Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey. Mov Disord. 2007 Mar 15; 22(4):509-14.
    View in: PubMed
  65. Rizzo M, Glick TH. Medical errors after stroke: preventable or inevitable? Neurology. 2007 Feb 20; 68(8):542-3.
    View in: PubMed
  66. Holloway RG, Tuttle D, Baird T, Skelton WK. The safety of hospital stroke care. Neurology. 2007 Feb 20; 68(8):550-5.
    View in: PubMed
  67. Little DM, Holloway RG. Diffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture? Neurology. 2007 Jan 2; 68(1):9-10.
    View in: PubMed
  68. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007 Jan; 22(1):41-7.
    View in: PubMed
  69. Dorsey ER, Vitticore P, De Roulet J, Thompson JP, Carrasco M, Johnston SC, Holloway RG, Moses H. Financial anatomy of neuroscience research. Ann Neurol. 2006 Dec; 60(6):652-9.
    View in: PubMed
  70. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007 Jan 30; 68(5):384-6.
    View in: PubMed
  71. Kelly AG, Holloway RG. Review: noninvasive imaging techniques may be useful for diagnosing 70% to 99% carotid stenosis in symptomatic patients. ACP J Club. 2006 Nov-Dec; 145(3):77.
    View in: PubMed
  72. Johnston KC, Holloway RG. There is nothing staid about STARD: progress in the reporting of diagnostic accuracy studies. Neurology. 2006 Sep 12; 67(5):740-1.
    View in: PubMed
  73. Dorsey ER, Holloway RG, Ravina BM. Biomarkers in Parkinson's disease. Expert Rev Neurother. 2006 Jun; 6(6):823-31.
    View in: PubMed
  74. Henry JC, Holloway R. Review: lorazepam provides the best control for status epilepticus. Evid Based Med. 2006 Apr; 11(2):54.
    View in: PubMed
  75. Noyes K, Liu H, Holloway RG. What is the risk of developing parkinsonism following neuroleptic use? Neurology. 2006 Mar 28; 66(6):941-3.
    View in: PubMed
  76. Holloway RG, Józefowicz RF. Update in neurology. Ann Intern Med. 2006 Mar 21; 144(6):421-6.
    View in: PubMed
  77. Kim SY, Holloway RG, Frank S, Beck CA, Zimmerman C, Wilson R, Kieburtz K. Volunteering for early phase gene transfer research in Parkinson disease. Neurology. 2006 Apr 11; 66(7):1010-5.
    View in: PubMed
  78. Henry JC, Holloway R. Review: Lorazepam provides the best control for status epilepticus. ACP J Club. 2006 Mar-Apr; 144(2):35.
    View in: PubMed
  79. Noyes K, Liu H, Li Y, Holloway R, Dick AW. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov Disord. 2006 Mar; 21(3):362-72.
    View in: PubMed
  80. Noyes K, Dick AW, Holloway RG. Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life. Value Health. 2006 Jan-Feb; 9(1):28-38.
    View in: PubMed
  81. Holloway R. The Babinski sign: thumbs up or toes down? Neurology. 2005 Oct 25; 65(8):1147.
    View in: PubMed
  82. Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R, Hess D, Saver J, Spence JD, Stern B, Wilterdink J. Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005 Sep 27; 65(6):794-801.
    View in: PubMed
  83. Holloway R. Protein-energy supplementation of normal hospital diet did not improve outcomes after recent stroke. ACP J Club. 2005 Sep-Oct; 143(2):36.
    View in: PubMed
  84. Holloway R. Timing and route of enteral tube-feeding did not reduce death or poor outcome in stroke and dysphagia. ACP J Club. 2005 Sep-Oct; 143(2):37.
    View in: PubMed
  85. Kim SY, Frank S, Holloway R, Zimmerman C, Wilson R, Kieburtz K. Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers. Arch Neurol. 2005 Sep; 62(9):1357-60.
    View in: PubMed
  86. Holloway RG, Benesch CG, Burgin WS, Zentner JB. Prognosis and decision making in severe stroke. JAMA. 2005 Aug 10; 294(6):725-33.
    View in: PubMed
  87. Frank S, Kieburtz K, Holloway R, Kim SY. What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports. Neurology. 2005 Oct 11; 65(7):1101-3.
    View in: PubMed
  88. Williams LS, Holloway RG. How much is a good night's sleep worth? Stroke. 2005 Jun; 36(6):1293-4.
    View in: PubMed
  89. Guttuso T, Vitticore P, Holloway RG. Responsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report. J Neurosurg. 2005 Mar; 102(3):547-9.
    View in: PubMed
  90. Lindsay MP, Kapral MK, Gladstone D, Holloway R, Tu JV, Laupacis A, Grimshaw JM. The Canadian Stroke Quality of Care Study: establishing indicators for optimal acute stroke care. CMAJ. 2005 Feb 1; 172(3):363-5.
    View in: PubMed
  91. Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langston JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, Powers W, Seibyl J, Sethi KD, Shults CW, Sheehy P, Stoessl AJ, Holloway R. The role of radiotracer imaging in Parkinson disease. Neurology. 2005 Jan 25; 64(2):208-15.
    View in: PubMed
  92. Holloway RG. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2005 Jan 11; 64(1):172-4; author reply 172-4.
    View in: PubMed
  93. Noyes K, Dick AW, Holloway RG. Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness. Pharmacoeconomics. 2005; 23(12):1257-70.
    View in: PubMed
  94. Noyes K, Dick AW, Holloway RG. Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial. Med Decis Making. 2004 Sep-Oct; 24(5):472-85.
    View in: PubMed
  95. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004 Sep; 19(9):1020-8.
    View in: PubMed
  96. Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis. Neurology. 2004 Aug 24; 63(4):718-20.
    View in: PubMed
  97. Holloway R, Nesbit K, Bordley D, Noyes K. Teaching and evaluating first and second year medical students' practice of evidence-based medicine. Med Educ. 2004 Aug; 38(8):868-78.
    View in: PubMed
  98. Tuttle D, Holloway R, Baird T, Sheehan B, Skelton WK. Electronic reporting to improve patient safety. Qual Saf Health Care. 2004 Aug; 13(4):281-6.
    View in: PubMed
  99. Noyes K, Holloway RG. Evidence from cost-effectiveness research. NeuroRx. 2004 Jul; 1(3):348-55.
    View in: PubMed
  100. Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004 Jul; 61(7):1044-53.
    View in: PubMed
  101. Holloway RG, Siderowf AD. Evidence-based neurotherapeutics: a spectrum of evidence. NeuroRx. 2004 Jul; 1(3):295-7.
    View in: PubMed
  102. Holloway R, Frank S. Review: anticholinergic drugs improve motor function and disability in Parkinson disease. ACP J Club. 2004 Jan-Feb; 140(1):15.
    View in: PubMed
  103. Holloway R, Dick AW. Editorial comment--stroke cost-effectiveness research: are acceptability curves acceptable? Stroke. 2004 Jan; 35(1):203-4.
    View in: PubMed
  104. Frank S, Holloway R. Medical errors on an inpatient neurology service. Neurology. 2003 Jul 22; 61(2):254-7.
    View in: PubMed
  105. Kim SY, Holloway RG. Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis. Am J Psychiatry. 2003 Jul; 160(7):1272-6.
    View in: PubMed
  106. Biglan KM, Holloway RG. Surrogate endpoints in Parkinson's disease research. Curr Neurol Neurosci Rep. 2003 Jul; 3(4):314-20.
    View in: PubMed
  107. Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J. Development and testing of the Parkinson's disease quality of life scale. Mov Disord. 2003 Jun; 18(6):637-45.
    View in: PubMed
  108. Nodera H, Herrmann DN, Holloway RG, Logigian EL. A Bayesian argument against rigid cut-offs in electrodiagnosis of median neuropathy at the wrist. Neurology. 2003 Feb 11; 60(3):458-64.
    View in: PubMed
  109. Gottlieb RH, La TC, Erturk EN, Sotack JL, Voci SL, Holloway RG, Syed L, Mikityansky I, Tirkes AT, Elmarzouky R, Zwemer FL, Joseph JV, Davis D, DiGrazio WJ, Messing EM. CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes. Radiology. 2002 Nov; 225(2):441-9.
    View in: PubMed
  110. Robling M, Matthews SJ, Hood K, Russell IT, Holloway R, Wilkinson C, Edwards AG, Austoker J, Cohen D, Mansel R, Pill RM, Stott NC, Thapar A. The development of a new site-specific measure of quality of life for breast problems: the Cardiff breast scales. Qual Life Res. 2002 Jun; 11(4):339-48.
    View in: PubMed
  111. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA. 2002 Apr 3; 287(13):1653-61.
    View in: PubMed
  112. Holloway RG, Dick AW. Clinical trial end points: on the road to nowhere? Neurology. 2002 Mar 12; 58(5):679-86.
    View in: PubMed
  113. Biglan KM, Holloway RG. A review of pramipexole and its clinical utility in Parkinson's disease. Expert Opin Pharmacother. 2002 Feb; 3(2):197-210.
    View in: PubMed
  114. Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis. Neurology. 2001 Nov 13; 57(9):1566-70.
    View in: PubMed
  115. Kissel JT, McDermott MP, Mendell JR, King WM, Pandya S, Griggs RC, Tawil R. Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology. 2001 Oct 23; 57(8):1434-40.
    View in: PubMed
  116. Holloway RG, Vickrey BG, Benesch C, Hinchey JA, Bieber J. Development of performance measures for acute ischemic stroke. Stroke. 2001 Sep; 32(9):2058-74.
    View in: PubMed
  117. Tomaszewski KJ, Holloway RG. Deep brain stimulation in the treatment of Parkinson's disease: a cost-effectiveness analysis. Neurology. 2001 Aug 28; 57(4):663-71.
    View in: PubMed
  118. Biglan K, Holloway RG. Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials. Curr Neurol Neurosci Rep. 2001 Jul; 1(4):329-36.
    View in: PubMed
  119. Pippenger M, Holloway RG, Vickrey BG. Neurologists' use of ICD-9CM codes for dementia. Neurology. 2001 May 8; 56(9):1206-9.
    View in: PubMed
  120. Holloway RG, Panzer RJ. Lawyers, litigation, and liability: can they make patients safer? Neurology. 2001 Apr 24; 56(8):991-3.
    View in: PubMed
  121. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group. Neurology. 2000 Nov 28; 55(10):1540-7.
    View in: PubMed
  122. Holloway RG, Ringel SP, Bernat JL, Keran CM, Lawyer BL. US neurologists: attitudes on rationing. Neurology. 2000 Nov 28; 55(10):1492-7.
    View in: PubMed
  123. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. JAMA. 2000 Oct 18; 284(15):1931-8.
    View in: PubMed
  124. Gifford DR, Holloway RG, Vickrey BG. Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia. Arch Intern Med. 2000 Oct 9; 160(18):2855-62.
    View in: PubMed
  125. Holloway RG, Benesch C, Rush SR. Stroke prevention: narrowing the evidence-practice gap. Neurology. 2000 May 23; 54(10):1899-906.
    View in: PubMed
  126. Siderowf AD, Holloway RG, Stern MB. Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions. Mov Disord. 2000 May; 15(3):439-45.
    View in: PubMed
  127. Zivin JA, Holloway RG. Weighing the evidence on DWI: caveat emptor. Neurology. 2000 Apr 25; 54(8):1552.
    View in: PubMed
  128. Larson WL, Holloway RG, Keran CM. Employment-seeking experiences of residents in 1996: a window into the neurology marketplace. Neurology. 2000 Jan 11; 54(1):214-8.
    View in: PubMed
  129. A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Parkinson Study Group. Clin Neuropharmacol. 2000 Jan-Feb; 23(1):34-44.
    View in: PubMed
  130. Holloway RG, Kantrowitz JT, St James EC, Giang D, Schwarz K. Resolution of transient ischemic attacks and aortic arch thrombi on anticoagulant therapy. Eur Neurol. 2000; 43(3):184-5.
    View in: PubMed
  131. Holloway RG, Feasby TE. To test or not to test? That is the question. Neurology. 1999 Dec 10; 53(9):1905-7.
    View in: PubMed
  132. Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS. 1999 Sep 10; 13(13):1677-85.
    View in: PubMed
  133. Gifford DR, Holloway RG, Frankel MR, Albright CL, Meyerson R, Griggs RC, Vickrey BG. Improving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial. Ann Intern Med. 1999 Aug 17; 131(4):237-46.
    View in: PubMed
  134. Holloway RG, Gifford DR, Frankel MR, Vickrey BG. A randomized trial to implement practice recommendations: design and methods of the Dementia Care Study. Control Clin Trials. 1999 Aug; 20(4):369-85.
    View in: PubMed
  135. Holloway RG, Benesch CG, Rahilly CR, Courtright CE. A systematic review of cost-effectiveness research of stroke evaluation and treatment. Stroke. 1999 Jul; 30(7):1340-9.
    View in: PubMed
  136. Holloway RG, Vickrey BG, Keran CM, Lesser E, Iverson D, Larson W, Swarztrauber K. US neurologists in the 1990's: trends in practice characteristics. Neurology. 1999 Apr 22; 52(7):1353-61.
    View in: PubMed
  137. Schifitto G, Holloway R. Cerebrovascular disease in patients with HIV-1 associated pulmonary hypertension. J NeuroAIDS. 1999; 2(2):57-64.
    View in: PubMed
  138. Uchino A, Numaguchi Y, Holloway RG, Cherian N. Reversible symptomatic venous congestion after treatment of dural arteriovenous fistula using NBCA. Radiat Med. 1998 Nov-Dec; 16(6):477-81.
    View in: PubMed
  139. Hoerger TJ, Bala MV, Rowland C, Greer M, Chrischilles EA, Holloway RG. Cost effectiveness of pramipexole in Parkinson's disease in the US. Pharmacoeconomics. 1998 Nov; 14(5):541-57.
    View in: PubMed
  140. Holloway RG, Courtright CE, Rahilly CR, Totterman SM, Shrier D. Magnetic resonance imaging in delayed brachial plexopathy following a clavicular fracture. Eur Neurol. 1998 Aug; 40(2):105-6.
    View in: PubMed
  141. Holloway RG, Ringel SP. Narrowing the evidence-practice gap. Strengthening the link between research and clinical practice. Neurology. 1998 Feb; 50(2):319-21.
    View in: PubMed
  142. Holloway RG, Witter DM, Mushlin AI, Lawton KB, McDermott MP, Samsa GP. Carotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995. Arch Neurol. 1998 Jan; 55(1):25-32.
    View in: PubMed
  143. Mushlin AI, Mooney C, Holloway RG, Detsky AS, Mattson DH, Phelps CE. The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms. Int J Technol Assess Health Care. 1997; 13(1):21-34.
    View in: PubMed
  144. Holloway RG. Cost-effectiveness analysis: what is it and how will it influence neurology. Ann Neurol. 1996 Jun; 39(6):818-23.
    View in: PubMed
  145. Holloway RG, Mushlin AI. Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy. Neurology. 1996 Apr; 46(4):1010-5.
    View in: PubMed
  146. Holloway RG, Witter DM, Lawton KB, Lipscomb J, Samsa G. Inpatient costs of specific cerebrovascular events at five academic medical centers. Neurology. 1996 Mar; 46(3):854-60.
    View in: PubMed
  147. Kieburtz K, Ketonen L, Cox C, Grossman H, Holloway R, Booth H, Hickey C, Feigin A, Caine ED. Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection. Arch Neurol. 1996 Feb; 53(2):155-8.
    View in: PubMed
  148. Holloway RG, Kieburtz KD. Headache and the human immunodeficiency virus type 1 infection. Headache. 1995 May; 35(5):245-55.
    View in: PubMed
  149. Kiss I, Deák F, Holloway RG, Delius H, Mebust KA, Frimberger E, Argraves WS, Tsonis PA, Winterbottom N, Goetinck PF. Structure of the gene for cartilage matrix protein, a modular protein of the extracellular matrix. Exon/intron organization, unusual splice sites, and relation to alpha chains of beta 2 integrins, von Willebrand factor, complement factors B and C2, and epidermal growth factor. J Biol Chem. 1989 May 15; 264(14):8126-34.
    View in: PubMed

Visualizations


Holloway's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department